Publications

Oral versus transdermal estrogens and venous thromboembolism in postmenopausal women: what is new since 2003?. Canonico, M.; Scarabin, P. Y.. Menopause.. 2016; 587-8: p.587-8
    Article
    Comparative efficacy of fingolimod vs natalizumab: A French multicenter observational study. Barbin, Laetitia; Rousseau, Chloe; Jousset, Natacha; Casey, Romain; Debouverie, Marc; Vukusic, Sandra; De Sèze, Jerome; Brassat, David; Wiertlewski, Sandrine; Brochet, Bruno; Pelletier, Jean; Vermersch, Patrick; Edan, Gilles; Lebrun-Frenay, Christine; Clavelou, Pierre; Thouvenot, Eric; Camdessanché, Jean-Philippe; Tourbah, Ayman; Stankoff, Bruno; Al Khedr, Abdullatif; Cabre, Philippe; Papeix, Caroline; Berger, Eric; Heinzlef, Olivier; Debroucker, Thomas; Moreau, Thibault; Gout, Olivier; Bourre, Bertrand; Créange, Alain; Labauge, Pierre; Magy, Laurent; Defer, Gilles; Foucher, Yohann; Laplaud, David A.; CFSEP and OFSEP groups. Neurology. 2016; 771-778: p.771-778. doi:10.1212/WNL.0000000000002395
      Article
      Risk factors for substances use and misuse among young people in France: What can we learn from the Substance Use Risk Profile Scale?. Ali, A.; Carré, A.; Hassler, C.; Spilka, S.; Vanier, A.; Barry, C.; Berthoz, S.. Drug and Alcohol Dependence. 2016; 84-91: p.84-91. doi:10.1016/j.drugalcdep.2016.03.027
        Article
        Low parathyroid hormone status induced by high dialysate calcium is an independent risk factor for cardiovascular death in hemodialysis patients. Merle, Emilie; Roth, Hubert; London, Gérard M.; Jean, Guillaume; Hannedouche, Thierry; Bouchet, Jean-Louis; Drüeke, Tilman; Fouque, Denis; Daugas, Eric; French Calcium and Phosphate Observatory. Kidney International. 2016; 666-674: p.666-674. doi:10.1016/j.kint.2015.12.001
          Article
          Activin receptor IIA ligand trap in chronic kidney disease: 1 drug to prevent 2 complications-or even more?. Massy, Ziad A.; Drüeke, Tilman B.. Kidney International. 2016; 1180-1182: p.1180-1182. doi:10.1016/j.kint.2016.02.006
            Article
            Antiretroviral resistance at virological failure in the NEAT 001/ANRS 143 trial: raltegravir plus darunavir/ritonavir or tenofovir/emtricitabine plus darunavir/ritonavir as first-line ART. Lambert-Niclot, S.; George, EC.; Pozniak, A.; White, E.; Schwimmer, C.; Jessen, H.; Johnson, M.; Dunn, D.; Perno, CF.; Clotet, B.; Plettenberg, A.; Blaxhult, A.; Palmisano, L.; Wittkop, L.; Calvez, V.; Marcelin, AG.; Raffi, F.; NEAT 001/ANRS 143 Study Group.. J Antimicrob Chemother. 2016; 71: p.1056–62. doi:doi: 10.1093/jac/dkv427. Epub 2015 Dec 24
            Article
            Innovations for phase I dose-finding designs in pediatric oncology clinical trials. Doussau, A.; Geoerger, B.; Jimenez, I.; Paoletti, X.. Contemp Clin Trials. 2016; 217-27: p.217-27. doi:10.1016/j.cct.2016.01.009 10.1016/j.cct.2016.01.009. Epub 2016 Jan 26.

            Article
            45 or 50 Gy, Which is the Optimal Radiotherapy Pelvic Dose in Locally Advanced Cervical Cancer in the Perspective of Reaching Magnetic Resonance Image-guided Adaptive Brachytherapy Planning Aims?. Mazeron, R.; Petit, C.; Rivin, E.; Limkin, E.; Dumas, I.; Maroun, P.; Annede, P.; Martinetti, F.; Seisen, T.; Lefkopoulos, D.; Chargari, C.; Haie-Meder, C.. Clin Oncol (R Coll Radiol). 2016; 171-7: p.171-7. doi:10.1016/j.clon.2015.10.008 10.1016/j.clon.2015.10.008. Epub 2015 Nov 5.

            Article
            Modèles cognitivo-comportementaux des addictions. Aubin, H.J.; Skanavi, S.. In: Reynaud, M.; Karila, L; Aubin, H.J.; Benyamina, A.. Traité d'addictologie (2° Éd.). Paris: Lavoisier Médecine Sciences; 2016. p.p.104-111.
              Book section
              Plaisirs, passions et addictions. Reynaud, M.. In: Reynaud, M.. Traité d'addictologie (2° Éd.). Paris: Lavoisier Médecine Sciences; 2016. p.p.781-795.
                Book section